Wolverine Trading, LLC Fulgent Genetics, Inc. Call Options Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$21.55 - $29.29 $357,730 - $486,214	16,600 New	16,600 $360,000
Q1 2023 May 15, 2023	SELL	$29.39 - $36.27 $1.11 Million - $1.37 Million	-37,800 Reduced 61.17%	24,000 $713,000
Q4 2022 Feb 14, 2023	BUY	$29.23 - $40.28 $81,844 - $112,784	2,800 Added 4.75%	61,800 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $2.24 Million - $3.76 Million	59,000 New	59,000 $2.29 Million
Q2 2022 Aug 15, 2022	SELL	$47.98 - $62.75 $1.44 Million - $1.89 Million	-30,100 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $493,515 - $951,489	-9,900 Reduced 24.75%	30,100 $1.89 Million
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $2.18 Million - $2.96 Million	-28,200 Reduced 41.35%	40,000 $4.07 Million
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $681,317 - $1.01 Million	-9,100 Reduced 11.77%	68,200 $6.13 Million
Q2 2021 Aug 06, 2021	SELL	$66.8 - $100.45 $26,720 - $40,180	-400 Reduced 0.51%	77,300 $7.4 Million
Q1 2021 May 14, 2021	BUY	$59.3 - $183.85 $2.88 Million - $8.94 Million	48,600 Added 167.01%	77,700 $7.18 Million
Q4 2020 Feb 12, 2021	BUY	$31.01 - $52.1 $902,391 - $1.52 Million	29,100 New	29,100 $1.48 Million

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $534M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.